Article

Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways

2023-09-18

Abstract excerpt

Alzheimer’s Disease (AD) is a disorder characterized by cognitive decline, neurodegeneration, and accumulation of amyloid plaques and tau neurofibrillary tangles in the brain. Dysregulation of epigenetic histone modifications may lead to expression of transcriptional programs that play a role either in protecting against disease genesis or in worsening of disease pathology. One such histone modification, acetylati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ef249f3c-dc57-5e37-8f08-ba94c08f51c4
DOI: 10.1101/2023.09.18.558276

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathwaysDOI 10.1101/2023.09.18.558276Read

Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathwaysSemantic proximity Read

A histone acetylome-wide association study of Alzheimer’s disease: neuropathology-associated regulatory variation in the human entorhinal cortexSemantic proximity Read

Epigenetic Mechanisms in Alzheimer's DiseaseSemantic proximity Read

Cell type-specific histone acetylation profiling of Alzheimer’s Disease subjects and integration with geneticsSemantic proximity Read

CHAS, a deconvolution tool, infers cell type-specific signatures in bulk brain histone acetylation studies of neurological and psychiatric disordersSemantic proximity Read

Epigenetic mechanisms in Alzheimer's disease.Semantic proximity Read

Cell type-specific histone acetylation profiling of Alzheimer’s disease subjects and integration with geneticsSemantic proximity Read

Tip60 protects against amyloid-β peptide-induced transcriptomic alterations via different modes of action in early versus late stages of neurodegenerative progressionSemantic proximity Read

Characterization of the chromatin accessibility in an Alzheimer’s disease (AD) mouse modelSemantic proximity Read

HDAC inhibitor–dependent transcriptome and memory reinstatement in cognitive decline modelsSemantic proximity Read

Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker?Semantic proximity Read

Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer’s diseaseSemantic proximity Read